4//SEC Filing
Khosrovi Behzad 4
Accession 0001437749-12-010290
CIK 0001389545other
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 4:38 PM ET
Size
4.9 KB
Accession
0001437749-12-010290
Insider Transaction Report
Form 4
Khosrovi Behzad
VP Research and Development
Transactions
- Award
Option (right to buy)
2012-10-10+25,000→ 511,283 totalExercise: $1.29From: 2013-10-10Exp: 2022-10-10→ Common Stock (25,000 underlying)
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeother
Related Parties
1- filerCIK 0001410078
Filing Metadata
- Form type
- 4
- Filed
- Oct 11, 8:00 PM ET
- Accepted
- Oct 12, 4:38 PM ET
- Size
- 4.9 KB